Although bendamustine treatment largely depleted the MM cells (Fig. 4D, right), there were some instances of bendamustine-resistant myeloma cells which were positive for VE-cadherin (Fig. 4E). This evidence concerns the gene CDH5 and plasma cell myeloma.